Brief: Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality Growth
16/03/2026 10:37
March 16 (Reuters) - Genscript Biotech Corp 1548.HK: GENSCRIPT BIOTECH CORP REPORTS STRONG FY2025 RESULTS AS INTEGRATED PLATFORM STRATEGY AND GLOBAL EXECUTION DRIVE HIGH-QUALITY GROWTH Source text: ID:nPrey3r6Sa Further company coverage: 1548.HK ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale